Cancer treatment–related bone loss: a review and synthesis of the literature
2008

Cancer Treatment and Bone Loss

Sample size: 9366 publication Evidence: moderate

Author Information

Author(s): Aliya A. Khan, M. N. Khan, A. A. Khan

Primary Institution: McMaster University

Hypothesis

Cancer therapy can lead to significant bone loss and increased fracture risk.

Conclusion

Bisphosphonates and other antiresorptive agents can help prevent bone loss associated with cancer treatments.

Supporting Evidence

  • Chemotherapy and hormonal treatments can lead to significant bone density loss.
  • Bisphosphonates have shown effectiveness in preventing bone loss during cancer treatments.
  • Patients on androgen deprivation therapy have a higher risk of fractures.

Takeaway

Cancer treatments can make your bones weak, but certain medicines can help keep your bones strong.

Methodology

The paper reviews existing literature on the effects of cancer treatments on bone health and the efficacy of various treatments for bone loss.

Potential Biases

The studies reviewed may have biases due to the comparison of treatments with tamoxifen, which has protective effects on bones.

Limitations

Many clinical trials have small sample sizes and do not include long-term follow-up.

Participant Demographics

The study primarily involves postmenopausal women and men undergoing androgen deprivation therapy.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 0.51 to 0.92

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication